Legal & General Group PLC Palatin Technologies Inc Transaction History

Legal & General Group PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$0.41 - $0.73 $15,167 - $27,004	-36,993 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$0.36 - $0.79 $3,042 - $6,675	-8,450 Reduced 18.59%	36,993 $16,000
Q4 2019 Feb 13, 2020	BUY	$0.75 - $0.89 $6,208 - $7,367	8,278 Added 22.27%	45,443 $36,000
Q1 2019 May 15, 2019	BUY	$0.67 - $1.01 $5,307 - $8,000	7,921 Added 27.09%	37,165 $36,000
Q2 2018 Aug 10, 2018	BUY	$0.91 - $1.45 $26,612 - $42,403	29,244 New	29,244 $28,000

2.94K

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $9.48M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.